Recall Register

Food, drugs, devices › Vascular Solutions, Inc.

Device recall: Dolphin Inflation Device, REF 0185NA. Rx only, Sterilized using Ethylene Oxide. DOLPHIN is a single-use, sterile inflati

FDA enforcement event 77095 · Class II · initiated 12 Apr 2017 · status Terminated · terminated 11 Apr 2018

DeviceVoluntary: Firm initiated1 product recordMaple Grove, MN

FDA enforcement event 77095 is a device recall by Vascular Solutions, Inc. of Maple Grove, MN, initiated 12 Apr 2017 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 11 Apr 2018. Initiation: voluntary: firm initiated. Vascular Solutions, Inc. has 12 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Vascular Solutions, Inc., Maple Grove, MN.

Reason for recall

"The manufacturer of the DOLPHIN inflation device, Perouse Medical, has initiated a recall of the device due to a potential defect in the sterile barrier. Use of affected product could pose a risk of microbial contamination, leading to infection."

Distribution

"US Distribution including PR and to the states of : LA, TN, CA, SC, OR, WA, OK, NV, HI, OH, TX."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2180-2017Dolphin Inflation Device, REF 0185NA. Rx only, Sterilized using Ethylene Oxide. DOLPHIN is a single-use, sterile inflation device used in cardiovascular procedures to pressurize (inflate) and depressurize (deflate) balloon catheters. The device itself consists of two components - the inflation device and large volume…4,110Class IITerminated7 Jun 2017

Context

93%of 2017 device events are Class II1,091 events that year
1product record in this eventfirm median: 1
12events on this register for the firm

Other enforcement events for Vascular Solutions, Inc.

InitiatedProduct (first record)TypeClassRecords
31 Aug 2020Langston Dual Lumen CatheterDeviceClass I4
16 Mar 2020Langston Dual Lumen Catheter 6F Model 5540. For delivery of contrast medium in angiographic studiesDeviceClass I1
4 May 2018Drainer(R) Centesis Catheters: (a) REF 8810, 5F x 9cm (b) REF 8811, 6F x 9cm (c) REF 8812, 5F x 15cm Product The DrainerDeviceClass II1
25 Apr 2017Venture RX Catheter, Model 5820; Venture OTW Catheter, Model 5821; Venture CS Catheter, Model 5822. Sterilized using ethDeviceClass I1
12 Jan 2017GrebSet Micro-Introducer Kit, model 7941, Sterilized with Ethylene Oxide. Product Usage: The GrebSet micro-introducer kiDeviceClass II1
16 Sep 2016Vascular Solutions Twin-Pass Dual Access Catheter, models 5200, 5210, and 5230. Sterilized with Ethylene Oxide. The TwinDeviceClass I3
4 Mar 2016Guardian II Hemostasis Valve, models 8210 and 8211. The following models are only available Outside the US: FH101, FH101DeviceClass I1
27 May 2014Langston Dual Lumen Catheters, 6Fr, REF 5550 and 5540. The Vascular Solutions Langston Dual Lumen Pressure Monitoring caDeviceClass I1
27 Feb 2013Vascular Solutions, Inc., Guardian II and Guardian II NC Hemostasis Valve, used in cardiopulmonary bypass. Model numbersDeviceClass I1
29 Jan 2013Vascular Solutions, SuperCross Microcatheter, Sterilized using ethylene oxide, Rx Only, Model numbers 5300 - 5307, 5324,DeviceClass II1

All 12 events for Vascular Solutions, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The manufacturer of the DOLPHIN inflation device, Perouse Medical, has initiated a recall of the device due to a potential defect in the sterile barrier. Use of affected product could pose a risk of microbial contamination, leading to infection."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US Distribution including PR and to the states of : LA, TN, CA, SC, OR, WA, OK, NV, HI, OH, TX."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 11 Apr 2018. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.